BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 7920665)

  • 21. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
    Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
    Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
    Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
    Constância M; Dean W; Lopes S; Moore T; Kelsey G; Reik W
    Nat Genet; 2000 Oct; 26(2):203-6. PubMed ID: 11017078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
    Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
    J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
    Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
    Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast.
    Walsh C; Miller SJ; Flam F; Fisher RA; Ohlsson R
    Cancer Res; 1995 Mar; 55(5):1111-6. PubMed ID: 7866996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of imprinted genes in human carcinogenesis].
    Ogawa O; Mishina M; Yoshida O
    Nihon Rinsho; 1995 Apr; 53(4):1009-16. PubMed ID: 7752460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biallelic transcription of Igf2 and H19 in individual cells suggests a post-transcriptional contribution to genomic imprinting.
    Jouvenot Y; Poirier F; Jami J; Paldi A
    Curr Biol; 1999 Oct; 9(20):1199-202. PubMed ID: 10531031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas.
    Rainho CA; Pontes A; Rogatto SR
    Gynecol Oncol; 1999 Sep; 74(3):375-80. PubMed ID: 10479496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
    Kondo M; Takahashi T
    Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
    J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic imprinting in the rat: linkage of Igf2 and H19 genes and opposite parental allele-specific expression during embryogenesis.
    Overall M; Bakker M; Spencer J; Parker N; Smith P; Dziadek M
    Genomics; 1997 Oct; 45(2):416-20. PubMed ID: 9344669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
    Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
    Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.